ARTICLE
8 February 2017

HRSA Publishes Final Rule On 340B Drug Pricing Program Ceiling Price And Manufacturer Civil Monetary Penalties

The Health Resources and Services Administration (HRSA) has published a final rule to implement CMP provisions added to section 340B of the Public Health Service Act under the Affordable Care Act.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

The Health Resources and Services Administration (HRSA) has published a final rule to implement civil money penalty (CMP) provisions added to section 340B of the Public Health Service Act under the Affordable Care Act. In particular, the final rule addresses: (i) the calculation of the 340B "ceiling price" that may be charged to covered entities; (ii) the substantive standards applicable to CMPs; and (iii) the procedures applicable to the imposition of CMPs. While the January 5, 2017 final rule sets forth a March 6, 2017 effective date, this rule is presumably impacted by the Trump Administration regulatory review policy, which will push back the effective date to March 21, 2017.

This article is presented for informational purposes only and is not intended to constitute legal advice.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More